Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-31 Purchase |
2022-05-31 5:13 pm |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
28,000 | $0.18 | $5,040 | 148,319 (Direct) |
View |
| 2022-03-03 Purchase |
2022-03-09 4:03 pm |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
76,246 | $0.391 | $29,812 | 110,319 (Direct) |
View |
| 2020-08-17 Purchase |
2020-08-18 08:35 am |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
5,000 | $1 | $5,000 | 12,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-20 Option Award |
2024-02-22 4:37 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:06 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
6,432 | $0 | 21,851 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:35 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
8,000 | $0 | 15,419 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-12-12 6:29 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
1,488 | $1.734 | 7,419 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-11-08 5:40 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,314 | $1.734 | 13,245 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-07 4:33 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,314 | $1.734 | 155,633 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-05 4:03 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
10,000 | $0.1863 | 120,319 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:03 pm |
N/A 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-05 2:54 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,787 | $0.718 | 34,073 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 5:11 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
9,563 | $0.567 | 26,286 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:02 pm |
N/A 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-11-03 Option Award |
2020-11-05 5:42 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
4,723 | $0.561 | 16,723 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 8:55 pm |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
49,955 | $0 | 49,955 (Direct) |
View |